糖尿病微血管病变评估中糖化血红蛋白检测的价值分析

The Value of Glycosylated Hemoglobin in the Evaluation of Diabetic Microangiopathy

目的分析糖尿病微血管病变评估中糖化血红蛋白检测的价值。方法从2016年2月—2017年5月来我院体检的健康者中、无血管病变糖尿病患者、微血管病变糖尿病患者中随机各抽取75例,设为对照组、无血管病DM组和微血管病变DM组。比较糖化血糖蛋白检测值。结果无血管病变DM组的空腹血糖FBG值与糖化血红蛋白(Hb A1c)值明显高于对照组(P<0.05);微血管病变DM组的空腹血糖FBG值和糖化血红蛋白(Hb A1c)值明显高于无血管病变DM组(P<0.05)。结论糖化血红蛋白检测能够反映糖尿病患者是否发生微血管病变,可作为糖尿病微血管病变的诊断依据之一。

Objective To evaluate the value of glycosylated hemoglobin in the assessment of diabetic microangiopathy. Methods From February 2016 to May 2017, healthy people, non-vascular diabetic patients, microangiopathy diabetic patients were randomly selected 75 cases in our hospital for physical examination,were nemed as the control group, no vascular disease DM group and microvascular disease DM group. The values of glycosylated hemoglobin were compared. Results The fasting blood glucose FBG and HbA1c in DM group were significantly higher than those in control group （P 〈 0.05）. The fasting blood glucose FBG and HbA1c in DM group were signifcantly higher than those in control group Lesion DM group （P 〈 0.05）. Conclusion Glycated hemoglobin test can refect the occurrence of microvascular disease in diabetic patients and may be used as a diagnostic basis for diabetic microangiopathy.